Investigator

Tarik K. Yuce

Indiana University School of Medicine, Surgery

Research Interests

TKYTarik K. Yuce
Papers(1)
Association between s…
Institutions(1)
University Of Chicago

Papers

Association between surgical approach and survival following resection of abdominopelvic malignancies

AbstractBackground and ObjectivesRecent studies demonstrating decreased survival following minimally invasive surgery (MIS) for cervical cancer have generated concern regarding oncologic efficacy of MIS. Our objective was to evaluate the association between surgical approach and 5‐year survival following resection of abdominopelvic malignancies.MethodsPatients with stage I or II adenocarcinoma of the prostate, colon, rectum, and stage IA2 or IB1 cervical cancer from 2010‐2015 were identified from the National Cancer Data Base. The association between surgical approach and 5‐year survival was assessed using propensity‐score‐matched cohorts. Distributions were compared using logistic regression. Hazard ratio for death was estimated using Cox proportional‐hazard models.ResultsThe rate of deaths at 5 years was 3.4% following radical prostatectomy, 22.9% following colectomy, 18.6% following proctectomy, and 6.8% following radical hysterectomy. Open surgery was associated with worse survival following radical prostatectomy (HR, 1.18; 95% CI, 1.05‐1.33; P = .005), colectomy (HR, 1.45; 95% CI, 1.39‐1.51; P < .001), and proctectomy (HR, 1.28; 95% CI, 1.10‐1.50; P = .002); however, open surgery was associated with improved survival following radical hysterectomy (HR, 0.61; 95% CI, 0.44‐0.82; P = .003).ConclusionsThese results suggest that MIS is an acceptable approach in selected patients with prostate, colon, and rectal cancers, while concerns regarding MIS resection of cervical cancer appear warranted.

27Works
1Papers
Abdominal NeoplasmsAdenocarcinomaColonic NeoplasmsPelvic NeoplasmsProstatic NeoplasmsRectal NeoplasmsUterine Cervical Neoplasms

Positions

Researcher

Indiana University School of Medicine · Surgery

Links & IDs
0000-0002-4575-6368

Scopus: 57220113965